Fixed-dose streptozotocin combined with high-fat diet induces a stable type 2 diabetes-like phenotype in C57BL/6J mice
Disease Models & Mechanisms · 2026
DOI: 10.1242/dmm.053071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Claes Fryklund und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden. Hauptthemen laut MEDLINE: Diet, High-Fat, Diabetes Mellitus, Type 2, Streptozocin. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MultiPark, Olle Engkvist's Foundation, Royal Physiographic Society of Lund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
High-fat diet (HFD) combined with streptozotocin (STZ) is widely used to model type 2 diabetes (T2D) in rodents, but is often associated with high mortality, non-responders and inconsistent outcomes. STZ is conventionally administered using body weight-adjusted dosing (mg/kg), despite evidence that heavier animals, including HFD-fed mice, exhibit more severe glycaemic responses. Here, we performed metabolic phenotyping in chow- and HFD-fed C57BL/6J mice treated with low or high fixed doses (mg instead of mg/kg) of anomer-equilibrated STZ. HFD combined with low-dose STZ induced a stable T2D-like phenotype characterized by sustained obesity, moderate hyperglycaemia, insulin resistance and partial β-cell loss, with low inter-individual variability. In contrast, high-dose STZ induced a type 1 diabetes-like phenotype, with extensive β-cell loss. A semi-mechanistic mathematical model was developed and validated against independent experimental data, reproducing the observed dynamics of fasting glucose in response to fixed-dose STZ. The model further predicted that weight-adjusted (mg/kg) dosing could introduce variability in glycaemic responses, particularly in HFD-fed mice. Together, these results demonstrate that fixed-dose, anomer-equilibrated STZ induces a stable T2D-like phenotype, providing an alternative to conventional weight-adjusted dosing in HFD-fed mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden.
ORCID-Profile: Claes Fryklund, Christian Simonsson, Josefin Malmberg, Karin G Stenkula, Maria Swanberg
Förderung
- MultiPark
- Olle Engkvist's Foundation
- Royal Physiographic Society of Lund
- Inga and John Hain Foundation
- Bertil and Ebon Norlins Foundation
- Parkinsonfonden
- Anna-Lisa Rosenberg Foundation
- Parkinson Research Foundation
Zitieren
APA
Fryklund, C., Simonsson, C., Hellberg, A., Malmberg, J., Stenkula, K. G., & Swanberg, M. (2026). Fixed-dose streptozotocin combined with high-fat diet induces a stable type 2 diabetes-like phenotype in C57BL/6J mice. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.053071
Vancouver
Fryklund C, Simonsson C, Hellberg A, Malmberg J, Stenkula KG, Swanberg M. Fixed-dose streptozotocin combined with high-fat diet induces a stable type 2 diabetes-like phenotype in C57BL/6J mice. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.053071
BibTeX
@article{Fryklund2026,
author = {Fryklund, Claes and Simonsson, Christian and Hellberg, Alexandra and Malmberg, Josefin and Stenkula, Karin G and Swanberg, Maria},
title = {Fixed-dose streptozotocin combined with high-fat diet induces a stable type 2 diabetes-like phenotype in C57BL/6J mice},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.053071}
}
EUVIMED